Quoc-Dien Trinh: I had the immense honor of delivering the Journal of Urology plenary lecture at the American Urological Association annual meeting

Toni Choueiri shared a post by Quoc-Dien Trinh, Chief of Urology at Brigham and Women’s Faulkner Hospital, shared a post on LinkedIn:

“Can’t expect less from Quoc-Dien Trinh! A super star surgeon, scientist and leader Brigham and Women’s Hospital!”

Source: Toni Choueiri/LinkedIn and Quoc-Dien Trinh/LinkedIn

Quoting Quoc-Dien Trinh‘s post:

“A week ago, I had the immense honor of delivering the Journal of Urology plenary lecture at the American Urological Association annual meeting in San Antonio, where I discussed our efforts to address racial disparities in access to prostate cancer care. This lecture provided a platform to showcase a decade of research and our ongoing Mass General Brigham system-wide initiative aimed at improving prostate cancer care for communities of color in Massachusetts and beyond.

I am deeply grateful to our patients, collaborators, and mentors who have supported this journey.

There is still much work to be done, and we are committed to continuing our progress in this vital area.”

Toni Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is the Medical Director of International Strategic Initiatives at Dana-Farber and past President of the Medical Staff at DFCI (2016-2018).

He received the George Canellos Award for Excellence in Clinical Investigation and Patient Care from DFCI in 2013, the Eugene Schonfeld Award from the Kidney Cancer Association (KCA) in 2016, and is a 2021 Giants of Cancer Care inductee. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, KidneyCan Board, the National Cancer Institute (NCI) GU Steering Committee, and is past Chairman (2015-2018) of the Medical and Scientific Steering Committee of the KCA.

Dr. Choueiri is an elected member of the American Society of Clinical Investigation (ASCI). In addition, he is an Aresty Scholar from the Wharton School of Business at the University of Pennsylvania.